Gaye Ellis
| Position | Research Coordinator (WCH) / Research Nurse (Medicine) |
|---|---|
| Department | Department of Women's and Children's Health (Dunedin) |
| Research summary | Female Urinary Incontinence |
Research
I am responsible for co-ordinating the pharmaceutical, surgical and conservative treatment clinical studies for women with urinary frequency, urgency, and urge and stress incontinence.My research interests include the following new therapies under investigation:
- a follow-up study for Tension Free Vaginal Tape surgery
- RCT of newly developed drugs for urinary problems.
Publications
Sukkar, L., Talbot, B., Jun, M., Dempsey, E., Walker, R., Hooi, L., … on behalf of the SHARP-ER Study Collaborators, including McGregor, D., & Ellis, G. (2019). Protocol for the study of heart and renal protection-extended review: Additional 5-year follow-up of the Australian, New Zealand, and Malaysian SHARP cohort. Canadian Journal of Kidney Health & Disease, 6, 1-11. doi: 10.1177/2054358119879896
Dean, N., Ellis, G., Herbison, G. P., Wilson, D., & Mashayekhi, A. (2017). Laparoscopic colposuspension for urinary incontinence in women (Review). Cochrane Database of Systematic Reviews, 7, CD002239. doi: 10.1002/14651858.CD002239.pub3
Weiner, I. D., Leader, J. P., Bedford, J. J., Verlander, J. W., Ellis, G., Kalita, P., Vos, F., de Jong, S., & Walker, R. J. (2014). Effects of chronic lithium administration on renal acid excretion in humans and rats. Physiological Reports, 2(12), e12242. doi: 10.14814/phy2.12242
Madhuvrata, P., Cody, J. D., Ellis, G., Herbison, G. P., & Hay-Smith, E. J. C. (2012). Which anticholinergic drug for overactive bladder symptoms in adults (Review). Cochrane Database of Systematic Reviews, 1, CD005429. doi: 10.1002/14651858.CD005429.pub2
Herbison, P., Hay-Smith, J., Paterson, H., Ellis, G., & Wilson, D. (2009). Research priorities in urinary incontinence: Results from citizens' juries. BJOG, 116(5), 713-718. doi: 10.1111/j.1471-0528.2008.02093.x
Journal - Research Article
Dean, N., Ellis, G., Herbison, G. P., Wilson, D., & Mashayekhi, A. (2017). Laparoscopic colposuspension for urinary incontinence in women (Review). Cochrane Database of Systematic Reviews, 7, CD002239. doi: 10.1002/14651858.CD002239.pub3
Weiner, I. D., Leader, J. P., Bedford, J. J., Verlander, J. W., Ellis, G., Kalita, P., Vos, F., de Jong, S., & Walker, R. J. (2014). Effects of chronic lithium administration on renal acid excretion in humans and rats. Physiological Reports, 2(12), e12242. doi: 10.14814/phy2.12242
Madhuvrata, P., Cody, J. D., Ellis, G., Herbison, G. P., & Hay-Smith, E. J. C. (2012). Which anticholinergic drug for overactive bladder symptoms in adults (Review). Cochrane Database of Systematic Reviews, 1, CD005429. doi: 10.1002/14651858.CD005429.pub2
Herbison, P., Hay-Smith, J., Paterson, H., Ellis, G., & Wilson, D. (2009). Research priorities in urinary incontinence: Results from citizens' juries. BJOG, 116(5), 713-718. doi: 10.1111/j.1471-0528.2008.02093.x
Bedford, J. J., Weggery, S., Ellis, G., McDonald, F. J., Joyce, P. R., Leader, J. P., & Walker, R. J. (2008). Lithium-induced nephrogenic diabetes insipidus: Renal effects of amiloride. Clinical Journal of the American Society of Nephrology, 3(5), 1324-1331.
Lauti, M., Herbison, P., Hay-Smith, J., Ellis, G., & Wilson, D. (2008). Anticholinergic drugs, bladder retraining and their combination for urge urinary incontinence: A pilot randomised trial. International Urogynecology Journal, 19, 1533-1543. doi: 10.1007/s00192-008-0686-8
Nabi, G., Cody, J. D., Ellis, G., Hay-Smith, J., & Herbison, G. P. (2006). Anticholinergic drugs versus placebo for overactive bladder syndrome in adults (Review). Cochrane Database of Systematic Reviews, 4, CD003781. doi: 10.1002/14651858.CD003781.pub2
Dean, N., Herbison, P., Ellis, G., & Wilson, D. (2006). Laparoscopic colposuspension and tension-free vaginal tape: A systematic review. BJOG, 113, 1345-1353.
Dean, N. M., Ellis, G., Wilson, P. D., & Herbison, G. P. (2006). Laparoscopic colposuspension for urinary incontinence in women (Review). Cochrane Database of Systematic Reviews, 3, CD002239. doi: 10.1002/14651858.CD002239.pub2
Hay-Smith, J., Herbison, P., Ellis, G., & Morris, A. (2005). Which anticholinergic drug for overactive bladder symptoms in adults (Review). Cochrane Database of Systematic Reviews, 3, CD005429. doi: 10.1002/14651858.CD005429
Walker, R. J., Weggery, S., Bedford, J. J., McDonald, F. J., Ellis, G., & Leader, J. P. (2005). Lithium-induced reduction in urinary concentrating ability and urinary aquaporin 2 (AQP2) excretion in healthy volunteers. Kidney International, 67, 291-294.
Dietz, P., Mouritsen, L., Ellis, G., & Wilson, P. D. (2005). How important is TVT location? Obstetrical & Gynecological Survey, 60(1), 25-26.
Dietz, H. P., Ellis, G., Wilson, P. D., & Herbison, P. (2004). Voiding function after tension-free vaginal tape: A longitudinal study. Australian & New Zealand Journal of Obstetrics & Gynaecology, 44(2), 152-155.
Dietz, H. P., Mouritsen, L., Ellis, G., & Wilson, P. D. (2004). How important is TVT location? Acta Obstetricia et Gynecologica Scandinavica, 83(10), 904-908.
Herbison, G. P., Hay-Smith, E. J. C., Ellis, G., & Moore, K. (2003). Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: Systematic review. British Medical Journal, 326, 841-844.
Dietz, H. P., Mouritsen, L., Ellis, G., & Wilson, P. D. (2003). Does the tension-free vaginal tape stay where you put it? American Journal of Obstetrics & Gynecology, 188(4), 950-953.
Dietz, H. P., Mouritsen, L., Ellis, G., & Wilson, P. D. (2002). Voiding function after TVT. International Urogynecology Journal, 13, S21.
Dietz, H. P., Mouritsen, L., Ellis, G., & Wilson, P. D. (2002). Does it matter where you put your tape? International Urogynecology Journal & Pelvic Floor Dysfunction, 13, S21.
Journal - Research Other
Sukkar, L., Talbot, B., Jun, M., Dempsey, E., Walker, R., Hooi, L., … on behalf of the SHARP-ER Study Collaborators, including McGregor, D., & Ellis, G. (2019). Protocol for the study of heart and renal protection-extended review: Additional 5-year follow-up of the Australian, New Zealand, and Malaysian SHARP cohort. Canadian Journal of Kidney Health & Disease, 6, 1-11. doi: 10.1177/2054358119879896
